Adicet Bio Inc (ACET)
1.745
-0.06
(-3.59%)
USD |
NASDAQ |
Apr 26, 10:57
Adicet Bio Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2022 | 38.70M |
| December 31, 2021 | 9.73M |
| September 30, 2021 | 9.672M |
| June 30, 2021 | 9.271M |
| Date | Value |
|---|---|
| March 31, 2021 | 11.92M |
| December 31, 2020 | 17.90M |
| September 30, 2020 | 14.46M |
| June 30, 2020 | 4.387M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.387M
Minimum
Jun 2020
38.70M
Maximum
Mar 2022
14.51M
Average
10.83M
Median
Revenue (TTM) Benchmarks
| Sagimet Biosciences Inc | -- |
| Catalyst Pharmaceuticals Inc | 398.20M |
| Codexis Inc | 70.14M |
| Annexon Inc | -- |
| Inhibrx Inc | 1.80M |